Drug Shortage Report for GENTAMICIN INJECTION USP
Report ID | 128174 |
Drug Identification Number | 02470462 |
Brand name | GENTAMICIN INJECTION USP |
Common or Proper name | Gentamicin |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GENTAMICIN |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2 mL |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-11-09 |
Actual start date | |
Estimated end date | 2020-11-30 |
Actual end date | 2020-12-01 |
Shortage status | Resolved |
Updated date | 2020-12-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-09 | English | Compare |
v2 | 2020-11-09 | English | Compare |
v3 | 2020-11-09 | French | Compare |
v4 | 2020-11-10 | English | Compare |
v5 | 2020-12-03 | English | Compare |
v6 | 2020-12-03 | French | Compare |
Showing 1 to 6 of 6